🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Women have been under-represented in cardiovascular disease (#CVD) clinical trials even though CVD is the leading cause of death in women. Aarti M Thakkar et al. highlight multidisciplinary guidelines for #women across a spectrum of CVD👉 bit.ly/3nqRBaN #ECRJournal Erin D. Michos, M.D.

What questions surrounding the link between inflammation and #cardiovascular disease (#CVD) should clinical research be addressing? Arnold et al. provide an overview in this article 👉 bit.ly/3doE4e2 #ECRJournal #MedEd #atherosclerosis #ASCVD #CardioTwitter#CardioEd

#TricuspidValve ?! 😱#EuroEcho EACVI President Denisa Muraru LEYLA ELIF SADE Victoria Delgado Thor Edvardsen Hatem Soliman R. Fontes-Carvalho

“We have demonstrated that we are failing some female patients and that some are unnecessarily falling through the cracks with adverse, and sometimes fatal, consequences.”

Looking forward to talk about sex disparities in hypertension 👇

Women ages 35 and younger are 44% more likely to have an ischemic stroke than male peers newsroom.heart.org/news/women-age…

A good read👇 theguardian.com/society/2022/f…

«Menn må gjerne kvoteres inn på medisinstudiet. Så lenge vi er ferdig med debatten om kvinners kvotering til styrer» Bra av ⁦Anne Rokkan⁩! bt.no/btmeninger/kom…

Looking forward to #esccongress2022 and to talk more about this⬇️

Women are STILL less likely to receive guideline directed medical theraphy compared with men. Great talk by Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 at the #esccongress2022

Really exited to share our latest paper - out today in The Lancet with simultaneous #ESCCongress presentation: thelancet.com/journals/lance… We wanted to know whether patients with autoimmune disease had a higher risk of developing cardiovascular disease. A short 🧵

Great talk from @AnnabOhldieck at the #esccongress2022 Pay attention to your blood pressure! @FemaleheartB Eva Gerdts

Inflammation is bad for the heart and associated with left ventricular remodelling👇 pubmed.ncbi.nlm.nih.gov/35968808/

It is time to implement our knowledge on #sexdifferences into #ESCHypertension guidelines and clinical practice. It is important for the @FemaleheartB European Society of Cardiology

My brilliant friend and colleague, making us all proud❤️❤️

📚New #ECRJournal Article📚 Just Published! New editorial reviewing current evidence for sex differences in AS diagnosis and management 👩📊 📖 Access it here 👉 ow.ly/2NVR50MXO3R Eva Gerdts Helga Midtbø Juan Carlos Kaski ISCP / International Society of CV Pharmacotherapy Pablo Avanzas #CardioTwitter

Poster session works even better with prosecco! Congrats Anja with a great session🥂@FemaleheartB

Could not agree more with Alexander Vietheer! Put on your sex-spesific lenses when doing research! Congratulations on a wonderful trial lecture and defence! @FemaleheartB @medofak_uib

Senter for forskning på hjertesykdom hos kvinner ved UiB jobber med dette på daglig basis. Men det ville ikke vært mulig uten våre støttespillere inkludert @griegfoundation Sanitetskvinnene @hjertefondet dagensmedisin.no/forskning-hjer…

Great to be in Chicago at AHAMeetings